The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study

The impact of early neuraminidase inhibitor therapy on clinical outcomes in patients hospitalised with influenza A-related pneumonia: a multicenter, retrospective study

Abstract Background Guidelines emphasize prompt antiviral treatment in severe influenza patients. Although nearly a 50% of severe influenza present with pneumonia, the effect of early (≤ 2 days after illness onset) neuraminidase inhibitor (NAI) use on the clinical outcomes of influenza A-related pne...

Full description

Bibliographic Details
Main Authors: Liang Chen, Xiudi Han, Yan Li Li, Chunxiao Zhang, Xiqian Xing
Format: Article
Language:English
Published: BMC 2020-08-01
Series:BMC Infectious Diseases
Subjects:
Neuraminidase inhibitor
Influenza a
Community-acquired pneumonia
Clinical outcome
Online Access:http://link.springer.com/article/10.1186/s12879-020-05322-x

Internet

http://link.springer.com/article/10.1186/s12879-020-05322-x

Similar Items